# Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

> **NCT02994069** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Susanne Arnold** · enrollment: 80 (actual)

## Conditions studied

- Carcinoma, Squamous Cell
- Head and Neck Cancer

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** XRT

## Key facts

- **NCT ID:** NCT02994069
- **Lead sponsor:** Susanne Arnold
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-04-11
- **Primary completion:** 2024-09-03
- **Final completion:** 2029-10-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02994069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02994069, "Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02994069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*